ClinicalTrials.Veeva

Menu

Corail Stability at 5-Years Post-Total Hip Arthroplasty

L

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Status

Completed

Conditions

Total Hip Arthroplasty

Treatments

Other: Standard Post-Operative Clinic Visit
Other: Study-Specific Outcomes

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Total hip arthroplasty (THA) is the mainstay, definitive management for end-stage hip osteoarthritis. Despite improvements of surgical and patient factors, prosthesis-related complications continue to increase in number. This is contributed to by the greater number of such surgeries being completed, larger proportion of elderly individuals among the population, and younger patient age being offered surgical intervention. Specifically, implant loosening and associated migration, is the pathology most commonly yielding revision surgery. A previous study assessing migration of total hip prostheses found that the greatest degree of migration occurred in the first 2 weeks postoperatively, although implants were considered overall stable 2 year following surgery. Continued evaluation of implant migration at time points further from surgery, specifically at 5 years postoperatively, offers insight into long term complications rates. Assessing implant migration will be completed using various imaging modalities, radiostereometric analysis (RSA) and computed tomography (CT). Comparisons between RSA and CT imaging will allow for greater analysis with regards to characterization of implant migration and associated bony changes. Additionally, an individual's gut microbiome has been shown to correspond to their inflammatory and immune profile. Association between gut microbiome profile and implant migration will be assessed to determine if underlying relationship does exist.

Enrollment

48 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participated in the originally investigated cohort.
  • Minimum of 4-5 years post-operation

Exclusion criteria

  • Pregnancy
  • Unable to attend follow-up

Trial design

48 participants in 2 patient groups

Direct Anterior
Description:
Patients who underwent the Direct Anterior (DA) surgical approach
Treatment:
Other: Study-Specific Outcomes
Other: Standard Post-Operative Clinic Visit
Direct Lateral
Description:
Patients who underwent the Direct Lateral (DL) surgical approach
Treatment:
Other: Study-Specific Outcomes
Other: Standard Post-Operative Clinic Visit

Trial contacts and locations

1

Loading...

Central trial contact

Lyndsay Somerville; Brent Lanting

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems